QualityStocksNewsBreaks – Universal Ibogaine Inc. Appoints Seasoned Biopharm Exec as New CEO
Universal Ibogaine has announced the appointment of a new CEO: Dr. Rami Batal. Batal is a veteran biopharmaceutical industry executive and a healthcare professional with impressive expertise and a background in mental health, specifically substance use disorders. Batal has spent his career in biomedical innovation, specifically biopharmaceutical research, development and commercialization of medicines for pain and central nervous system disorders (“CNS”). He has worked with numerous multinational pharmaceutical companies and biotech startups, including, most recently, Antibe Therapeutics (TSX:ATE), where he oversaw the commercial readiness of otenaproxesul, a phase 3 pain/osteoarthritis drug candidate, which was recently outlicensed to Nuance Pharma for…
